NeoImmuneTech, Inc. (KOSDAQ: 950220)
South Korea
· Delayed Price · Currency is KRW 1,624.00
-121.00 (-6.93%)
Sep 10, 2024, 9:00 AM KST
NeoImmuneTech Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 |
| Net Income | -46,564 | -53,405 | -60,406 | -52,482 | -30,456 | -14,198 | Upgrade
|
| Depreciation & Amortization | 3,210 | 3,210 | 2,802 | 1,873 | 987.98 | 780.79 | Upgrade
|
| Loss (Gain) From Sale of Assets | 1.89 | 1.89 | 12.78 | 108.48 | - | 0.96 | Upgrade
|
| Loss (Gain) From Sale of Investments | - | - | - | - | -140.72 | - | Upgrade
|
| Stock-Based Compensation | 5,893 | 5,893 | 5,631 | 9,204 | 3,048 | 1,297 | Upgrade
|
| Provision & Write-off of Bad Debts | 225.98 | 225.98 | - | - | - | - | Upgrade
|
| Other Operating Activities | -762.37 | -2,138 | 2,909 | -271.91 | 1,513 | -2,041 | Upgrade
|
| Change in Other Net Operating Assets | -3,548 | -3,548 | 6,646 | 7,682 | -3,858 | -627.93 | Upgrade
|
| Operating Cash Flow | -41,545 | -49,761 | -42,405 | -33,887 | -28,906 | -14,788 | Upgrade
|
| Capital Expenditures | -96.48 | -791.39 | -2,477 | -2,710 | -1,087 | -433.15 | Upgrade
|
| Sale of Property, Plant & Equipment | - | - | 6.98 | - | - | 114.06 | Upgrade
|
| Investment in Securities | - | - | - | - | 5,676 | -5,789 | Upgrade
|
| Other Investing Activities | 2,578 | 2,715 | 836.55 | -1,119 | -424.97 | 1,944 | Upgrade
|
| Investing Cash Flow | 2,644 | 2,087 | -3,150 | -3,828 | 4,164 | -4,164 | Upgrade
|
| Long-Term Debt Repaid | - | -1,178 | -1,036 | -713.73 | -292.15 | -144.42 | Upgrade
|
| Net Debt Issued (Repaid) | -1,243 | -1,178 | -1,036 | -713.73 | -292.15 | -144.42 | Upgrade
|
| Issuance of Common Stock | - | 41.26 | 402.56 | 115,763 | 261.12 | 72,703 | Upgrade
|
| Other Financing Activities | - | - | - | 0 | - | 0 | Upgrade
|
| Financing Cash Flow | -1,244 | -1,136 | -633.32 | 115,049 | -31.03 | 72,558 | Upgrade
|
| Foreign Exchange Rate Adjustments | -547.42 | -97.54 | -3,075 | -682.37 | -0.53 | 6.78 | Upgrade
|
| Miscellaneous Cash Flow Adjustments | -0 | -0 | -0 | - | - | -0 | Upgrade
|
| Net Cash Flow | -40,691 | -48,908 | -49,263 | 76,652 | -24,774 | 53,613 | Upgrade
|
| Free Cash Flow | -41,641 | -50,552 | -44,881 | -36,596 | -29,993 | -15,221 | Upgrade
|
| Free Cash Flow Per Share | -421.52 | -511.41 | -454.42 | -384.18 | -362.92 | -186.94 | Upgrade
|
| Cash Interest Paid | 205.81 | 220.99 | 253.77 | 226.7 | 171.3 | 130.31 | Upgrade
|
| Cash Income Tax Paid | 104.5 | 133.62 | 58.2 | 32.91 | 9.86 | - | Upgrade
|
| Levered Free Cash Flow | -30,290 | -38,500 | -28,855 | -25,579 | -21,631 | -9,443 | Upgrade
|
| Unlevered Free Cash Flow | -30,150 | -38,360 | -28,692 | -25,442 | -21,515 | -9,361 | Upgrade
|
| Change in Net Working Capital | 3,510 | 5,874 | -7,347 | -7,836 | 1,873 | -431.85 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.